Freeline Therapeutics Holdings shares owned by UBS Group
Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Freeline Therapeutics Holdings
Tip: Access up to 7 years of quarterly data
All positions including Freeline Therapeutics Holdings held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Freeline Therapeutics Holdings by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $633k | 99k | 6.37 |
2023-09-30 | $147k | 34k | 4.30 |
2023-06-30 | $86k | 33k | 2.58 |
Top funds holding Freeline Therapeutics Holdings
View all funds holding Freeline Therapeutics Holdings